Value through Innovation27 July 2016

Clinical Study Results

  • GIOTRIF ® (afatinib) - Liver Diseases
    Clinical Study Number 1200.86
    Study Indication Liver Diseases
    Product GIOTRIF ® (afatinib)
    Generic Name Afatinib
    Lab Code
    Clinical Phase I
    Study Title

    Pharmacokinetics, safety and tolerability of different oral doses of afatinib, in  subjects with mild to moderate hepatic impairment compared to healthy   subjects—a phase I, single-dose, open-label, dose-escalation study in a matched   group design

    Study Document Trial synopsis 1200.86 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.